Asset Protection

Intellectual Property

• PENAO Pty Ltd enjoys strong patent protection of its asset across multiple jurisdictions, including Australia, Canada, China, the European Union, India, Japan, Switzerland, the UK and the USA.
• Based on its ongoing research and development activities, PENAO Pty Limited anticipates filing further patent applications directed to potential new intellectual property in areas such as: unique formulations, methods of manufacture, and use of PENAO and /or its novel derivatives in combination with other therapeutics.
• Therapeutic areas are not limited to breast cancer; NSCLC; pancreatic cancer; late-stage ovarian cancer; gliomas; cervical cancer; colorectal cancer; neuroblastoma; and other histologically or cytologically confirmed advanced solid tumours refractory to standard treatment, or for which no standard treatment exists.